Your browser doesn't support javascript.
SARS-CoV-2 Epidemiology on a Public University Campus in Washington State.
Weil, Ana A; Sohlberg, Sarah L; O'Hanlon, Jessica A; Casto, Amanda M; Emanuels, Anne W; Lo, Natalie K; Greismer, Emily P; Magedson, Ariana M; Wilcox, Naomi C; Kim, Ashley E; Back, Lewis; Frazar, Christian D; Pelle, Ben; Sibley, Thomas R; Ilcisin, Misja; Lee, Jover; Ryke, Erica L; Craft, J Chris; Schwabe-Fry, Kristen M; Fay, Kairsten A; Cho, Shari; Han, Peter D; Heidl, Sarah J; Pfau, Brian A; Truong, Melissa; Zhong, Weizhi; Srivatsan, Sanjay R; Harb, Katia F; Gottlieb, Geoffrey S; Hughes, James P; Nickerson, Deborah A; Lockwood, Christina M; Starita, Lea M; Bedford, Trevor; Shendure, Jay A; Chu, Helen Y.
  • Weil AA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Sohlberg SL; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • O'Hanlon JA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Casto AM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Emanuels AW; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Lo NK; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Greismer EP; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Magedson AM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Wilcox NC; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Kim AE; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Back L; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Frazar CD; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Pelle B; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Sibley TR; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Ilcisin M; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Lee J; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Ryke EL; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Craft JC; Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
  • Schwabe-Fry KM; Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
  • Fay KA; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Cho S; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Han PD; Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
  • Heidl SJ; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Pfau BA; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Truong M; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Zhong W; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Srivatsan SR; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Harb KF; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Gottlieb GS; Department of Environmental Health and Safety, University of Washington, Seattle, Washington, USA.
  • Hughes JP; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Nickerson DA; Department of Environmental Health and Safety, University of Washington, Seattle, Washington, USA.
  • Lockwood CM; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Starita LM; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Bedford T; Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
  • Shendure JA; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Chu HY; Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Open Forum Infect Dis ; 8(11): ofab464, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1528169
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

We aimed to evaluate a testing program to facilitate control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission at a large university and measure spread in the university community using viral genome sequencing.

METHODS:

Our prospective longitudinal study used remote contactless enrollment, daily mobile symptom and exposure tracking, and self-swab sample collection. Individuals were tested if the participant was exposed to a known SARS-CoV-2-infected person, developed new symptoms, or reported high-risk behavior (such as attending an indoor gathering without masking or social distancing), if a member of a group experiencing an outbreak, or at enrollment. Study participants included students, staff, and faculty at an urban public university during the Autumn quarter of 2020.

RESULTS:

We enrolled 16 476 individuals, performed 29 783 SARS-CoV-2 tests, and detected 236 infections. Seventy-five percent of positive cases reported at least 1 of the following symptoms (60.8%), exposure (34.7%), or high-risk behaviors (21.5%). Greek community affiliation was the strongest risk factor for testing positive, and molecular epidemiology results suggest that specific large gatherings were responsible for several outbreaks.

CONCLUSIONS:

A testing program focused on individuals with symptoms and unvaccinated persons who participate in large campus gatherings may be effective as part of a comprehensive university-wide mitigation strategy to control the spread of SARS-CoV-2.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: English Journal: Open Forum Infect Dis Year: 2021 Document Type: Article Affiliation country: Ofid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: English Journal: Open Forum Infect Dis Year: 2021 Document Type: Article Affiliation country: Ofid